To provide hospital pharmacists, cardiac catheterization laboratory directors, and hospital administrators with the most up-to-date information on the use of direct thrombin inhibitors in percutaneous coronary intervention.
This activity is designed for hospital pharmacists, cardiac catheterization laboratory directors, and hospital administrators. No prerequisites required.
The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, the participant should be able to:
- Assess the economic differences between direct thrombin inhibitors and traditional anticoagulants.
- Discuss the advantages and drawbacks of direct thrombin inhibitor therapy versus traditional anticoagulants.
- Examine techniques to prevent hemorrhagic complications during percutaneous coronary intervention.
- Interpret the findings from the Randomized Evaluation of PCI Linking Angiomax in Reduced Clinical Events (REPLACE-2) clinical trial.
The University of Tennessee College of Pharmacy (UTCOP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) to provide continuing education for pharmacists.
CREDIT DESIGNATION STATEMENT
This program is approved for 2 hours of credit (0.2 CEUs)
and is sponsored by the University of Tennessee College of Pharmacy who is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Program #064-000-05-208-H01.This continuing education activity was produced under the supervision of Glen E. Farr, PharmD, Associate Dean for Continuing Pharmacy Education, University of Tennessee College of Pharmacy.
The estimated time to complete this educational activity: 2 hours.
Release date: July 15, 2005. Expiration date: July 15, 2007.
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of University of Tennessee College of Pharmacy name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.
A participant, sponsor, faculty member, or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the UTCOP may contact the Associate Dean for Continuing Education in writing. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.
This program is supported by an educational grant from The Medicines Company.